Wang Q, Guo F, Jin Y, Ma Y. Applications of human organoids in the personalized treatment for digestive diseases. Signal Transduct. Target Ther. 2022;7:336.
Google Scholar
Nameirakpam J, Rikhi R, Rawat SS, Sharma J, Suri D. Genetics on early onset inflammatory bowel disease: An update. Genes Dis. 2020;7:93–106.
Google Scholar
Israelsen M, Juel HB, Detlefsen S, Madsen BS, Rasmussen DN, Larsen TR, et al. Metabolic and genetic risk factors are the strongest predictors of severity of alcohol-related liver fibrosis. Clin Gastroenterol. Hepatol. 2022;20:1784–1794.e1789.
Google Scholar
Na YR, Stakenborg M, Seok SH, Matteoli G. Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD. Nat Rev. Gastroenterol. Hepatol. 2019;16:531–43.
Google Scholar
Huby T, Gautier EL. Immune cell-mediated features of non-alcoholic steatohepatitis. Nat Rev. Immunol. 2022;22:429–43.
Google Scholar
Olesen CM, Coskun M, Peyrin-Biroulet L, Nielsen OH. Mechanisms behind efficacy of tumor necrosis factor inhibitors in inflammatory bowel diseases. Pharmacol Ther. 2016;159:110–9.
Google Scholar
André T, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt C, et al. Pembrolizumab in microsatellite-instability-high advanced colorectal cancer. N Engl. J. Med. 2020;383:2207–18.
Google Scholar
Peery AF, Crockett SD, Murphy CC, Jensen ET, Kim HP, Egberg MD, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: Update 2021. Gastroenterology. 2022;162:621–44.
Google Scholar
Schmidt MF, Schlesinger MJ. Fatty acid binding to vesicular stomatitis virus glycoprotein: a new type of post-translational modification of the viral glycoprotein. Cell. 1979;17:813–9.
Google Scholar
Chamberlain LH, Shipston MJ. The physiology of protein S-acylation. Physiol Rev. 2015;95:341–76.
Google Scholar
Linder ME, Deschenes RJ. Palmitoylation: policing protein stability and traffic. Nat Rev. Mol. Cell Biol. 2007;8:74–84.
Google Scholar
Smotrys JE, Linder ME. Palmitoylation of intracellular signaling proteins: regulation and function. Annu Rev. Biochem. 2004;73:559–87.
Google Scholar
SM F, Abrami L, Linder ME, Bamji SX, Dickinson BC, van der Goot FG. Mechanisms and functions of protein S-acylation. Nat Rev. Mol. Cell Biol. 2024;25:488–509.
Ko PJ, Dixon SJ. Protein palmitoylation and cancer. EMBO Rep. 2018;19:e46666.
Peng J, Liang D, Zhang Z. Palmitoylation of synaptic proteins: roles in functional regulation and pathogenesis of neurodegenerative diseases. Cell Mol. Biol. Lett. 2024;29:108.
Google Scholar
Cho E, Park M. Palmitoylation in Alzheimer’s disease and other neurodegenerative diseases. Pharmacol Res. 2016;111:133–51.
Google Scholar
Cheng WX, Ren Y, Lu MM, Xu LL, Gao JG, Chen D, et al. Palmitoylation in Crohn’s disease: current status and future directions. World J. Gastroenterol. 2021;27:8201–15.
Google Scholar
Lu Y, Zheng Y, Coyaud É, Zhang C, Selvabaskaran A, Yu Y, et al. Palmitoylation of NOD1 and NOD2 is required for bacterial sensing. Science. 2019;366:460–7.
Google Scholar
Zhang M, Zhou L, Xu Y, Yang M, Xu Y, Komaniecki GP, et al. A STAT3 palmitoylation cycle promotes T(H)17 differentiation and colitis. Nature. 2020;586:434–9.
Google Scholar
Hu D, Li Y, Wang X, Zou H, Li Z, Chen W, et al. Palmitoylation of NLRP3 modulates inflammasome activation and inflammatory bowel disease development. J Immunol. 2024;213:481–93.
Google Scholar
Zhao L, Zhang C, Luo X, Wang P, Zhou W, Zhong S, et al. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis. J Hepatol. 2018;69:705–17.
Google Scholar
Kim YC, Lee SE, Kim SK, Jang HD, Hwang I, Jin S, et al. Toll-like receptor mediated inflammation requires FASN-dependent MYD88 palmitoylation. Nat Chem. Biol. 2019;15:907–16.
Google Scholar
Yang S, Jia L, Xiang J, Yang G, Qiu S, Kang L, et al. KLF10 promotes nonalcoholic steatohepatitis progression through transcriptional activation of zDHHC7. EMBO Rep. 2022;23:e54229.
Google Scholar
Planey SL, Keay SK, Zhang CO, Zacharias DA. Palmitoylation of cytoskeleton associated protein 4 by DHHC2 regulates antiproliferative factor-mediated signaling. Mol Biol. Cell. 2009;20:1454–63.
Google Scholar
Liu L, Wang L, Liu L, Qu X, Zhao W, Ding J, et al. Acyltransferase zinc finger DHHC-type containing 2 aggravates gastric carcinoma growth by targeting Nrf2 signaling: a mechanism-based multicombination bionic nano-drug therapy. Redox Biol. 2024;70:103051.
Google Scholar
Oo HZ, Sentani K, Sakamoto N, Anami K, Naito Y, Uraoka N, et al. Overexpression of ZDHHC14 promotes migration and invasion of scirrhous type gastric cancer. Oncol Rep. 2014;32:403–10.
Google Scholar
Chen L, Xing X, Zhu Y, Chen Y, Pei H, Song Q, et al. Palmitoylation alters LDHA activity and pancreatic cancer response to chemotherapy. Cancer Lett. 2024;587:216696.
Google Scholar
Tomić G, Sheridan C, Refermat AY, Baggelaar MP, Sipthorp J, Sudarshan B, et al. Palmitoyl transferase ZDHHC20 promotes pancreatic cancer metastasis. Cell Rep. 2024;43:114224.
Google Scholar
Zhang H, Sun Y, Wang Z, Huang X, Tang L, Jiang K, et al. ZDHHC20-mediated S-palmitoylation of YTHDF3 stabilizes MYC mRNA to promote pancreatic cancer progression. Nat Commun. 2024;15:4642.
Google Scholar
Shan J, Li X, Sun R, Yao Y, Sun Y, Kuang Q, et al. Palmitoyltransferase ZDHHC6 promotes colon tumorigenesis by targeting PPARγ-driven lipid biosynthesis via regulating lipidome metabolic reprogramming. J Exp. Clin. Cancer Res. 2024;43:227.
Google Scholar
Zhang Q, Yang X, Wu J, Ye S, Gong J, Cheng WM, et al. Reprogramming of palmitic acid induced by dephosphorylation of ACOX1 promotes β-catenin palmitoylation to drive colorectal cancer progression. Cell Discov. 2023;9:26.
Google Scholar
Zhang Q, Du Z, Zhou W, Li W, Yang Q, Yu H, et al. ZDHHC1 downregulates LIPG and inhibits colorectal cancer growth via IGF2BP1 Palmitoylation. Cancer Gene Ther. 2024;31:1427–37.
Google Scholar
Zhou B, Wang Y, Zhang L, Shi X, Kong H, Zhang M, et al. The palmitoylation of AEG-1 dynamically modulates the progression of hepatocellular carcinoma. Theranostics. 2022;12:6898–914.
Google Scholar
Bu L, Zhang Z, Chen J, Fan Y, Guo J, Su Y, et al. High-fat diet promotes liver tumorigenesis via palmitoylation and activation of AKT. Gut. 2024;73:1156–68.
Google Scholar
Jiang Y, Xu Y, Zhu C, Xu G, Xu L, Rao Z, et al. STAT3 palmitoylation initiates a positive feedback loop that promotes the malignancy of hepatocellular carcinoma cells in mice. Sci Signal. 2023;16:eadd2282.
Google Scholar
Shu H, Peng Y, Hang W, Nie J, Zhou N, Wang DW. The role of CD36 in cardiovascular disease. Cardiovasc Res. 2022;118:115–29.
Google Scholar
Terry AR, Nogueira V, Rho H, Ramakrishnan G, Li J, Kang S, et al. CD36 maintains lipid homeostasis via selective uptake of monounsaturated fatty acids during matrix detachment and tumor progression. Cell Metab. 2023;35:2060–2076.e2069.
Google Scholar
Yao H, Lan J, Li C, Shi H, Brosseau JP, Wang H, et al. Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours. Nat Biomed. Eng. 2019;3:306–17.
Google Scholar
Carta G, Murru E, Banni S, Manca C. Palmitic acid: physiological role, metabolism and nutritional implications. Front Physiol. 2017;8:902.
Google Scholar
Kang J, Wu J, Liu Q, Jiang H, Li W, Li Y, et al. FASN regulates STING palmitoylation via malonyl-CoA in macrophages to alleviate sepsis-induced liver injury. Biochim Biophys. Acta Mol. Basis Dis. 2024;1870:167299.
Google Scholar
Fatima S, Hu X, Gong RH, Huang C, Chen M, Wong HLX, et al. Palmitic acid is an intracellular signaling molecule involved in disease development. Cell Mol. Life Sci. 2019;76:2547–57.
Google Scholar
Mitchell DA, Vasudevan A, Linder ME, Deschenes RJ. Protein palmitoylation by a family of DHHC protein S-acyltransferases. J Lipid Res. 2006;47:1118–27.
Google Scholar
Stix R, Lee CJ, Faraldo-Gómez JD, Banerjee A. Structure and mechanism of DHHC protein Acyltransferases. J Mol. Biol. 2020;432:4983–98.
Google Scholar
Greaves J, Chamberlain LH. DHHC palmitoyl transferases: substrate interactions and (patho)physiology. Trends Biochem Sci. 2011;36:245–53.
Google Scholar
Iwanaga T, Tsutsumi R, Noritake J, Fukata Y, Fukata M. Dynamic protein palmitoylation in cellular signaling. Prog Lipid Res. 2009;48:117–27.
Google Scholar
Rana MS, Kumar P, Lee CJ, Verardi R, Rajashankar KR, Banerjee A. Fatty acyl recognition and transfer by an integral membrane S-acyltransferase. Science. 2018;359:eaao6326.
Jennings BC, Linder ME. DHHC protein S-acyltransferases use similar ping-pong kinetic mechanisms but display different acyl-CoA specificities. J Biol. Chem. 2012;287:7236–45.
Google Scholar
Yuan Y, Li P, Li J, Zhao Q, Chang Y, He X. Protein lipidation in health and disease: molecular basis, physiological function and pathological implication. Signal Transduct. Target Ther. 2024;9:60.
Google Scholar
Ernst AM, Syed SA, Zaki O, Bottanelli F, Zheng H, Hacke M, et al. S-Palmitoylation sorts membrane cargo for anterograde transport in the golgi. Dev Cell. 2018;47:479–493.e477.
Google Scholar
Busquets-Hernández C, Triola G. Palmitoylation as a key regulator of ras localization and function. Front Mol. Biosci. 2021;8:659861.
Google Scholar
Rocks O, Peyker A, Kahms M, Verveer PJ, Koerner C, Lumbierres M, et al. An acylation cycle regulates localization and activity of palmitoylated Ras isoforms. Science. 2005;307:1746–52.
Google Scholar
Wang J, Hao JW, Wang X, Guo H, Sun HH, Lai XY, et al. DHHC4 and DHHC5 facilitate fatty acid uptake by palmitoylating and targeting CD36 to the plasma membrane. Cell Rep. 2019;26:209–221.e205.
Google Scholar
Hao JW, Wang J, Guo H, Zhao YY, Sun HH, Li YF, et al. CD36 facilitates fatty acid uptake by dynamic palmitoylation-regulated endocytosis. Nat Commun. 2020;11:4765.
Google Scholar
Jin J, Zhi X, Wang X, Meng D. Protein palmitoylation and its pathophysiological relevance. J Cell Physiol. 2021;236:3220–33.
Google Scholar
Zhou L, He X, Wang L, Wei P, Cai Z, Zhang S, et al. Palmitoylation restricts SQSTM1/p62-mediated autophagic degradation of NOD2 to modulate inflammation. Cell Death Differ. 2022;29:1541–51.
Google Scholar
Rossin A, Durivault J, Chakhtoura-Feghali T, Lounnas N, Gagnoux-Palacios L, Hueber AO. Fas palmitoylation by the palmitoyl acyltransferase DHHC7 regulates Fas stability. Cell Death Differ. 2015;22:643–53.
Google Scholar
Chen X, Niu W, Fan X, Yang H, Zhao C, Fan J, et al. Oct4A palmitoylation modulates tumorigenicity and stemness in human glioblastoma cells. Neuro Oncol. 2023;25:82–96.
Google Scholar
Qu M, Zhou X, Wang X, Li H. Lipid-induced S-palmitoylation as a vital regulator of cell signaling and disease development. Int J. Biol. Sci. 2021;17:4223–37.
Google Scholar
Liu Z, Xiao M, Mo Y, Wang H, Han Y, Zhao X, et al. Emerging roles of protein palmitoylation and its modifying enzymes in cancer cell signal transduction and cancer therapy. Int J. Biol. Sci. 2022;18:3447–57.
Google Scholar
Fritsch J, Särchen V, Schneider-Brachert W. Regulation of death receptor signaling by S-Palmitoylation and detergent-resistant membrane micro domains-greasing the gears of extrinsic cell death induction, survival, and inflammation. Cancers. 2021;13:2513.
Zhang Y, Qin Z, Sun W, Chu F, Zhou F. Function of protein S-Palmitoylation in immunity and immune-related diseases. Front Immunol. 2021;12:661202.
Google Scholar
Blaustein M, Piegari E, Martínez Calejman C, Vila A, Amante A, Manese MV, et al. Akt is S-Palmitoylated: a new layer of regulation for Akt. Front Cell Dev. Biol. 2021;9:626404.
Google Scholar
Zhang N, Zhang J, Yang Y, Shan H, Hou S, Fang H, et al. A palmitoylation-depalmitoylation relay spatiotemporally controls GSDMD activation in pyroptosis. Nat Cell Biol. 2024;26:757–69.
Google Scholar
Yang Y, Fang H, Xie Z, Ren F, Yan L, Zhang M, et al. Yersinia infection induces glucose depletion and AMPK-dependent inhibition of pyroptosis in mice. Nat Microbiol. 2024;9:2144–59.
Google Scholar
Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79:1542–56.
Google Scholar
Miao L, Targher G, Byrne CD, Cao YY, Zheng MH. Current status and future trends of the global burden of MASLD. Trends Endocrinol. Metab. 2024;35:697–707.
Google Scholar
Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021;184:2537–64.
Google Scholar
Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397:2212–24.
Google Scholar
Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24:908–22.
Google Scholar
Yan L, Zhang T, Wang K, Chen Z, Yang Y, Shan B, et al. SENP1 prevents steatohepatitis by suppressing RIPK1-driven apoptosis and inflammation. Nat Commun. 2022;13:7153.
Google Scholar
Zhang T, Zhang N, Xing J, Zhang S, Chen Y, Xu D, et al. UDP-glucuronate metabolism controls RIPK1-driven liver damage in nonalcoholic steatohepatitis. Nat Commun. 2023;14:2715.
Google Scholar
Zhang N, Liu J, Guo R, Yan L, Yang Y, Shi C, et al. Palmitoylation licenses RIPK1 kinase activity and cytotoxicity in the TNF pathway. Mol Cell. 2024;84:4419–4435.e4410.
Google Scholar
Tao N, Wagner SJ, Lublin DM. CD36 is palmitoylated on both N- and C-terminal cytoplasmic tails. J Biol. Chem. 1996;271:22315–20.
Google Scholar
Zeng S, Wu F, Chen M, Li Y, You M, Zhang Y, et al. Inhibition of Fatty Acid Translocase (FAT/CD36) palmitoylation enhances hepatic fatty acid β-Oxidation by increasing its localization to mitochondria and interaction with long-chain Acyl-CoA Synthetase 1. Antioxid Redox Signal. 2022;36:1081–1100.
Google Scholar
You M, Wu F, Gao M, Chen M, Zeng S, Zhang Y, et al. Selenoprotein K contributes to CD36 subcellular trafficking in hepatocytes by accelerating nascent COPII vesicle formation and aggravates hepatic steatosis. Redox Biol. 2022;57:102500.
Google Scholar
Wang L, Jia Z, Wang B, Zhang B. Berberine inhibits liver damage in rats with non-alcoholic fatty liver disease by regulating TLR4/MyD88/NF-κB pathway. Turk J. Gastroenterol. 2020;31:902–9.
Google Scholar
Tan X, Sun Y, Chen L, Hu J, Meng Y, Yuan M, et al. Caffeine ameliorates AKT-driven nonalcoholic steatohepatitis by suppressing De Novo lipogenesis and MyD88 palmitoylation. J Agric Food Chem. 2022;70:6108–22.
Google Scholar
Xu M, Ge C, Zhu L, Qin Y, Du C, Lou D, et al. iRhom2 promotes hepatic steatosis by activating MAP3K7-dependent pathway. Hepatology. 2021;73:1346–64.
Google Scholar
Ge CX, Xu MX, Qin YT, Gu TT, Lou DS, Li Q, et al. Endoplasmic reticulum stress-induced iRhom2 up-regulation promotes macrophage-regulated cardiac inflammation and lipid deposition in high fat diet (HFD)-challenged mice: Intervention of fisetin and metformin. Free Radic. Biol. Med. 2019;141:67–83.
Google Scholar
Xu M, Tan J, Zhu L, Ge C, Dong W, Dai X, et al. The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis via blocking inactive rhomboid protein 2-dependent pathway. Acta Pharm. Sin. B. 2023;13:1071–92.
Google Scholar
Xu M, Tan J, Dong W, Zou B, Teng X, Zhu L, et al. The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes. Nat Commun. 2022;13:1052.
Google Scholar
Xu M, Tan J, Zhu L, Ge C, Zhang Y, Gao F, et al. Palmitoyltransferase ZDHHC3 aggravates nonalcoholic steatohepatitis by targeting S-Palmitoylated IRHOM2. Adv Sci. 2023;10:e2302130.
Hameed S, Patterson M, Dhillo WS, Rahman SA, Ma Y, Holton C, et al. Thyroid hormone receptor beta in the ventromedial hypothalamus is essential for the physiological regulation of food intake and body weight. Cell Rep. 2017;19:2202–9.
Google Scholar
Greene MW, Burrington CM, Ruhoff MS, Johnson AK, Chongkrairatanakul T, Kangwanpornsiri APKC. delta is activated in a dietary model of steatohepatitis and regulates endoplasmic reticulum stress and cell death. J Biol. Chem. 2010;285:42115–29.
Google Scholar
Wang YH, Chen X, Bai YZ, Gao P, Yang Z, Guo Q, et al. Palmitoylation of PKCδ by ZDHHC5 in hypothalamic microglia presents as a therapeutic target for fatty liver disease. Theranostics. 2024;14:988–1009.
Google Scholar
Guo R, Liu J, Min X, Zeng W, Shan B, Zhang M, et al. Reduction of DHHC5-mediated beclin 1 S-palmitoylation underlies autophagy decline in aging. Nat Struct. Mol. Biol. 2024;31:232–45.
Google Scholar
Wang L, Cai J, Zhao X, Ma L, Zeng P, Zhou L, et al. Palmitoylation prevents sustained inflammation by limiting NLRP3 inflammasome activation through chaperone-mediated autophagy. Mol Cell. 2023;83:281–297.e210.
Google Scholar
Wei F, Wang Y, Yao J, Mei L, Huang X, Kong H, et al. ZDHHC7-mediated S-palmitoylation of ATG16L1 facilitates LC3 lipidation and autophagosome formation. Autophagy. 2024;20:2719–37.
Google Scholar
Wang Q, Bu Q, Xu Z, Liang Y, Zhou J, Pan Y, et al. Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy. Clin Mol. Hepatol. 2024;30:515–38.
Google Scholar
VSW Li. Modelling intestinal inflammation and infection using ‘mini-gut’ organoids. Nat Rev. Gastroenterol. Hepatol. 2021;18:89–90.
Lee M, Chang EB. Inflammatory Bowel Diseases (IBD) and the microbiome-searching the crime scene for clues. Gastroenterology. 2021;160:524–37.
Google Scholar
Neurath MF. Strategies for targeting cytokines in inflammatory bowel disease. Nat Rev. Immunol. 2024;24:559–76.
Google Scholar
Yang E, Shen J. The roles and functions of Paneth cells in Crohn’s disease: a critical review. Cell Prolif. 2021;54:e12958.
Google Scholar
de Bruyn M, Vermeire S. NOD2 and bacterial recognition as therapeutic targets for Crohn’s disease. Expert Opin. Ther. Targets. 2017;21:1123–39.
Google Scholar
Zhou L, Liu T, Huang B, Luo M, Chen Z, Zhao Z, et al. Excessive deubiquitination of NLRP3-R779C variant contributes to very-early-onset inflammatory bowel disease development. J Allergy Clin. Immunol. 2021;147:267–79.
Google Scholar
Li J, Wei Y, Liu C, Guo X, Liu Z, Zhang L, et al. 2’-Fucosyllactose restores the intestinal mucosal barrier in ulcerative colitis by inhibiting STAT3 palmitoylation and phosphorylation. Clin Nutr. 2024;43:380–94.
Google Scholar
Jiang X, Zhang X, Cai X, Li N, Zheng H, Tang M, et al. NU6300 covalently reacts with cysteine-191 of gasdermin D to block its cleavage and palmitoylation. Sci Adv. 2024;10:eadi9284.
Google Scholar
Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev. Drug Discov. 2018;17:588–606.
Google Scholar
Wang L, Hauenstein AV. The NLRP3 inflammasome: mechanism of action, role in disease and therapies. Mol Asp. Med. 2020;76:100889.
Google Scholar
Zheng S, Que X, Wang S, Zhou Q, Xing X, Chen L, et al. ZDHHC5-mediated NLRP3 palmitoylation promotes NLRP3-NEK7 interaction and inflammasome activation. Mol Cell. 2023;83:4570–4585.e4577.
Google Scholar
Yu T, Hou D, Zhao J, Lu X, Greentree WK, Zhao Q, et al. NLRP3 Cys126 palmitoylation by ZDHHC7 promotes inflammasome activation. Cell Rep. 2024;43:114070.
Google Scholar
Zhang Z, Li X, Yang F, Chen C, Liu P, Ren Y, et al. DHHC9-mediated GLUT1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis. Nat Commun. 2021;12:5872.
Google Scholar
Ali A, Levantini E, Teo JT, Goggi J, Clohessy JG, Wu CS, et al. Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non-small cell lung cancer. EMBO Mol Med. 2018;10:e8313.
Chen X, Ma H, Wang Z, Zhang S, Yang H, Fang Z. EZH2 palmitoylation mediated by ZDHHC5 in p53-mutant glioma drives malignant development and progression. Cancer Res. 2017;77:4998–5010.
Google Scholar
Zhou B, Hao Q, Liang Y, Kong E. Protein palmitoylation in cancer: molecular functions and therapeutic potential. Mol Oncol. 2023;17:3–26.
Google Scholar
Johnston FM, Beckman M. Updates on management of gastric cancer. Curr Oncol Rep. 2019;21:67.
Google Scholar
Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021;71:264–79.
Google Scholar
Yan SM, Tang JJ, Huang CY, Xi SY, Huang MY, Liang JZ, et al. Reduced expression of ZDHHC2 is associated with lymph node metastasis and poor prognosis in gastric adenocarcinoma. PLoS ONE. 2013;8:e56366.
Google Scholar
Peng C, Zhang Z, Wu J, Lv Z, Tang J, Xie H, et al. A critical role for ZDHHC2 in metastasis and recurrence in human hepatocellular carcinoma. Biomed Res Int. 2014;2014:832712.
Google Scholar
Gupta N, Manevich Y, Kazi AS, Tao JQ, Fisher AB, Bates SR. Identification and characterization of p63 (CKAP4/ERGIC-63/CLIMP-63), a surfactant protein A binding protein, on type II pneumocytes. Am J. Physiol. Lung Cell Mol. Physiol. 2006;291:L436–446.
Google Scholar
Kimura H, Yamamoto H, Harada T, Fumoto K, Osugi Y, Sada R, et al. CKAP4, a DKK1 receptor, is a biomarker in exosomes derived from pancreatic cancer and a molecular target for therapy. Clin Cancer Res. 2019;25:1936–47.
Google Scholar
Raisch J, Côté-Biron A, Rivard N. A role for the WNT Co-Receptor LRP6 in pathogenesis and therapy of epithelial cancers. Cancers. 2019;11:1162.
Sada R, Kimura H, Fukata Y, Fukata M, Yamamoto H, Kikuchi. A dynamic palmitoylation controls the microdomain localization of the DKK1 receptors CKAP4 and LRP6. Sci Signal. 2019;12:eaat9519.
Wang Y, Zhang S, He H, Luo H, Xia Y, Jiang Y, et al. Repositioning Lomitapide to block ZDHHC5-dependant palmitoylation on SSTR5 leads to anti-proliferation effect in preclinical pancreatic cancer models. Cell Death Discov. 2023;9:60.
Google Scholar
Lin Z, Huang K, Guo H, Jia M, Sun Q, Chen X, et al. Targeting ZDHHC9 potentiates anti-programmed death-ligand 1 immunotherapy of pancreatic cancer by modifying the tumor microenvironment. Biomed Pharmacother. 2023;161:114567.
Google Scholar
Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31–46.
Google Scholar
Fatima S, Hu X, Huang C, Zhang W, Cai J, Huang M, et al. High-fat diet feeding and palmitic acid increase CRC growth in β2AR-dependent manner. Cell Death Dis. 2019;10:711.
Google Scholar
Li P, Gong X, Yuan L, Mu L, Zheng Q, Xiao H, et al. Palmitoylation in apoptosis. J Cell Physiol. 2023;238:1641–50.
Google Scholar
Galluzzo P, Caiazza F, Moreno S, Marino M. Role of ERbeta palmitoylation in the inhibition of human colon cancer cell proliferation. Endocr Relat Cancer. 2007;14:153–67.
Google Scholar
Caiazza F, Galluzzo P, Lorenzetti S, Marino M. 17Beta-estradiol induces ERbeta up-regulation via p38/MAPK activation in colon cancer cells. Biochem Biophys Res Commun. 2007;359:102–7.
Google Scholar
Yi M, Niu M, Xu L, Luo S, Wu K. Regulation of PD-L1 expression in the tumor microenvironment. J Hematol Oncol. 2021;14:10.
Google Scholar
Yao H, Li C, He F, Song T, Brosseau JP, Wang H, et al. A peptidic inhibitor for PD-1 palmitoylation targets its expression and functions. RSC Chem Biol. 2021;2:192–205.
Google Scholar
Yang Y, Hsu JM, Sun L, Chan LC, Li CW, Hsu JL, et al. Palmitoylation stabilizes PD-L1 to promote breast tumor growth. Cell Res. 2019;29:83–86.
Google Scholar
Chen C, Zhao S, Karnad A, Freeman JW. The biology and role of CD44 in cancer progression: therapeutic implications. J Hematol Oncol. 2018;11:64.
Google Scholar
Yang Z, Qin W, Chen Y, Yuan B, Song X, Wang B, et al. Cholesterol inhibits hepatocellular carcinoma invasion and metastasis by promoting CD44 localization in lipid rafts. Cancer Lett. 2018;429:66–77.
Google Scholar
Zhu HD, Liao JZ, He XX, Li PY. The emerging role of astrocyte-elevated gene-1 in hepatocellular carcinoma (Review). Oncol Rep. 2015;34:539–46.
Google Scholar
Sun Y, Zhang H, Meng J, Guo F, Ren D, Wu H, et al. S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K/AKT pathway. Cell Rep. 2022;40:111194.
Google Scholar
Alannan M, Fatrouni H, Trézéguet V, Dittrich-Domergue F, Moreau P, Siegfried G, et al. Targeting PCSK9 in liver cancer cells triggers metabolic exhaustion and cell death by ferroptosis. Cells. 2022;12:62.
Shi Z, Li Z, Jin B, Ye W, Wang L, Zhang S, et al. Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de-palmitoylation. Clin Transl. Med. 2023;13:e1300.
Google Scholar
Jeong DW, Park JW, Kim KS, Kim J, Huh J, Seo J, et al. Palmitoylation-driven PHF2 ubiquitination remodels lipid metabolism through the SREBP1c axis in hepatocellular carcinoma. Nat Commun. 2023;14:6370.
Google Scholar
Huang J, Tsang WY, Fang XN, Zhang Y, Luo J, Gong LQ, et al. FASN inhibition decreases MHC-I degradation and synergizes with PD-L1 checkpoint blockade in hepatocellular carcinoma. Cancer Res. 2024;84:855–71.
Google Scholar
Xu J, Su Z, Cheng X, Hu S, Wang W, Zou T, et al. High PPT1 expression predicts poor clinical outcome and PPT1 inhibitor DC661 enhances sorafenib sensitivity in hepatocellular carcinoma. Cancer Cell Int. 2022;22:115.
Google Scholar
Luo Q, Li X, Gan G, Yang M, Chen X, Chen F. PPT1 reduction contributes to erianin-induced growth inhibition in oral squamous carcinoma cells. Front Cell Dev. Biol. 2021;9:764263.
Google Scholar
Rebecca VW, Nicastri MC, Fennelly C, Chude CI, Barber-Rotenberg JS, Ronghe A, et al. PPT1 promotes tumor growth and is the molecular target of chloroquine derivatives in cancer. Cancer Discov. 2019;9:220–9.
Google Scholar
Harding JJ, Awada A, Roth G, Decaens T, Merle P, Kotecki N, et al. First-in-human effects of PPT1 inhibition using the oral treatment with GNS561/Ezurpimtrostat in patients with primary and secondary liver cancers. Liver Cancer. 2022;11:268–77.
Google Scholar
Weng J, Liu S, Zhou Q, Xu W, Xu M, Gao D, et al. Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinoma. J Immunother Cancer. 2023;11:e006655.
Morgan E, Soerjomataram I, Rumgay H, Coleman HG, Thrift AP, Vignat J, et al. The Global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020. Gastroenterology. 2022;163:649–658.e642.
Google Scholar
Sun M, Peng Z, Shen W, Guo X, Liao Y, Huang Y, et al. Synergism of fusobacterium periodonticum and N-nitrosamines promote the formation of EMT subtypes in ESCC by modulating Wnt3a palmitoylation. Gut Microbes. 2024;16:2391521.
Google Scholar
Ni Q, Pan C, Han G. Modification-specific proteomic analysis reveals cysteine S-palmitoylation involved in esophageal cancer cell radiation. ACS Omega. 2025;10:1541–50.
Google Scholar
Liu X, Liu T, Shao Z, Xiong X, Qi S, Guan J, et al. Palmitoylation-dependent association with Annexin II directs hepatitis E virus ORF3 sorting into vesicles and quasi-enveloped virions. Proc Natl Acad Sci USA. 2025;122:e2418751122.
Google Scholar
Wang Y, Ma H, Zhang B, Li S, Lu B, Qi Y, et al. Protein palmitoylation in hepatic diseases: functional insights and therapeutic strategies. J Adv Res. 2024;26:S2090–1232(24)00619-2.
Qiu N, Abegg D, Guidi M, Gilmore K, Seeberger PH, Adibekian A. Artemisinin inhibits NRas palmitoylation by targeting the protein acyltransferase ZDHHC6. Cell Chem. Biol. 2022;29:530–537.e537.
Google Scholar
Sun Q, Yu X, Peng C, Liu N, Chen W, Xu H, et al. Activation of SREBP-1c alters lipogenesis and promotes tumor growth and metastasis in gastric cancer. Biomed Pharmacother. 2020;128:110274.
Google Scholar
Békés M, Langley DR, Crews CM. PROTAC targeted protein degraders: the past is prologue. Nat Rev. Drug Discov. 2022;21:181–200.
Google Scholar
Zhang N, Yang Y, Xu D. Emerging roles of palmitoylation in pyroptosis. Trends Cell Biol. 2024;35:500–14.
Pei S, Piao HL. Exploring protein S-palmitoylation: mechanisms, detection, and strategies for inhibitor discovery. ACS Chem. Biol. 2024;19:1868–82.
Google Scholar
Solis GP, Kazemzadeh A, Abrami L, Valnohova J, Alvarez C, van der Goot FG, et al. Local and substrate-specific S-palmitoylation determines subcellular localization of Gαo. Nat Commun. 2022;13:2072.
Google Scholar
Chen W, Guo L, Wei W, Cai C, Wu G. Zdhhc1- and Zdhhc2-mediated Gpm6a palmitoylation is essential for maintenance of mammary stem cell activity. Cell Rep. 2024;43:114762.
Google Scholar
Zhou Q, Lin H, Wang S, Wang S, Ran Y, Liu Y, et al. The ER-associated protein ZDHHC1 is a positive regulator of DNA virus-triggered, MITA/STING-dependent innate immune signaling. Cell Host Microbe. 2014;16:450–61.
Google Scholar
Sun Y, Zhu L, Liu P, Zhang H, Guo F, Jin X. ZDHHC2-Mediated AGK palmitoylation activates AKT-mTOR signaling to reduce sunitinib sensitivity in renal cell carcinoma. Cancer Res. 2023;83:2034–51.
Google Scholar
Li SX, Tang GS, Zhou DX, Pan YF, Tan YX, Zhang J, et al. Prognostic significance of cytoskeleton-associated membrane protein 4 and its palmitoyl acyltransferase DHHC2 in hepatocellular carcinoma. Cancer. 2014;120:1520–31.
Google Scholar
Chang Y, Zhu J, Li X, Deng Y, Lai B, Ma Y, et al. Palmitoylation regulates myelination by modulating the ZDHHC3-Cadm4 axis in the central nervous system. Signal Transduct Target Ther. 2024;9:254.
Google Scholar
Ni H, Wang Y, Yao K, Wang L, Huang J, Xiao Y, et al. Cyclical palmitoylation regulates TLR9 signalling and systemic autoimmunity in mice. Nat Commun. 2024;15:1.
Google Scholar
Zhao C, Yu H, Fan X, Niu W, Fan J, Sun S, et al. GSK3β palmitoylation mediated by ZDHHC4 promotes tumorigenicity of glioblastoma stem cells in temozolomide-resistant glioblastoma through the EZH2-STAT3 axis. Oncogenesis. 2022;11:28.
Google Scholar
Wang Y, Shen N, Yang Y, Xia Y, Zhang W, Lu Y, et al. ZDHHC5-mediated S-palmitoylation of FAK promotes its membrane localization and epithelial-mesenchymal transition in glioma. Cell Commun Signal. 2024;22:46.
Google Scholar
Wang Z, Wang Y, Shen N, Liu Y, Xu X, Zhu R, et al. AMPKα1-mediated ZDHHC8 phosphorylation promotes the palmitoylation of SLC7A11 to facilitate ferroptosis resistance in glioblastoma. Cancer Lett. 2024;584:216619.
Google Scholar
Li W, Liu J, Yu T, Lu F, Miao Q, Meng X, et al. ZDHHC9-mediated Bip/GRP78 S-palmitoylation inhibits unfolded protein response and promotes bladder cancer progression. Cancer Lett. 2024;598:217118.
Google Scholar
Gu M, Jiang H, Tan M, Yu L, Xu N, Li Y, et al. Palmitoyltransferase DHHC9 and acyl protein thioesterase APT1 modulate renal fibrosis through regulating β-catenin palmitoylation. Nat Commun. 2023;14:6682.
Google Scholar
Zheng Y, Chen J, Macwan V, Dixon CL, Li X, Liu S, et al. S-acylation of ATGL is required for lipid droplet homoeostasis in hepatocytes. Nat Metab. 2024;6:1549–65.
Google Scholar
Yuan M, Chen X, Sun Y, Jiang L, Xia Z, Ye K, et al. ZDHHC12-mediated claudin-3 S-palmitoylation determines ovarian cancer progression. Acta Pharm Sin B. 2020;10:1426–39.
Google Scholar
Wang L, Cui J. Palmitoylation promotes chaperone-mediated autophagic degradation of NLRP3 to modulate inflammation. Autophagy. 2023;19:2821–3.
Google Scholar
Tabata K, Imai K, Fukuda K, Yamamoto K, Kunugi H, Fujita T, et al. Palmitoylation of ULK1 by ZDHHC13 plays a crucial role in autophagy. Nat Commun. 2024;15:7194.
Google Scholar
Zhuang Z, Gu J, Li BO, Yang L. Inhibition of gasdermin D palmitoylation by disulfiram is crucial for the treatment of myocardial infarction. Transl Res. 2024;264:66–75.
Google Scholar
Koropouli E, Wang Q, Mejías R, Hand R, Wang T, Ginty DD, et al. Palmitoylation regulates neuropilin-2 localization and function in cortical neurons and conveys specificity to semaphorin signaling via palmitoyl acyltransferases. Elife. 2023;12:e83217.
Voytyuk O, Ohata Y, Moustakas A, Ten Dijke P, Heldin CH. Smad7 palmitoylation by the S-acyltransferase zDHHC17 enhances its inhibitory effect on TGF-β/Smad signaling. J Biol Chem. 2024;300:107462.
Google Scholar
Sun H, Cui Z, Li C, Gao Z, Xu J, Bian Y, et al. USP5 promotes Ripretinib resistance in gastrointestinal stromal tumors by MDH2 Deubiquition. Adv Sci. 2024;11:e2401171.
Shi C, Yang X, Liu Y, Li H, Chu H, Li G, et al. ZDHHC18 negatively regulates cGAS-mediated innate immunity through palmitoylation. Embo J. 2022;41:e109272.
Google Scholar
Huang X, Liu L, Yao J, Lin C, Xiang T, Yang A. S-acylation regulates SQSTM1/p62-mediated selective autophagy. Autophagy. 2024;20:1467–9.
Google Scholar
Runkle KB, Kharbanda A, Stypulkowski E, Cao XJ, Wang W, Garcia BA, et al. Inhibition of DHHC20-Mediated EGFR palmitoylation creates a dependence on EGFR Signaling. Mol Cell. 2016;62:385–96.
Google Scholar
Lu B, Sun YY, Chen BY, Yang B, He QJ, Li J, et al. zDHHC20-driven S-palmitoylation of CD80 is required for its costimulatory function. Acta Pharm Sin. 2024;45:1214–23.
Google Scholar
Huang X, Wang M, Zhang D, Meng J, Liu P. ZDHHC20 activates AKT signaling pathway to promote cell proliferation in hepatocellular carcinoma. J Hepatocell. Carcinoma. 2024;11:1763–75.
Google Scholar
Liu B, Zhao X, Zhang S, Li Q, Li X, Huang D, et al. Targeting ZDHHC21/FASN axis for the treatment of diffuse large B-cell lymphoma. Leukemia. 2024;38:351–64.
Google Scholar
Mill P, Lee AW, Fukata Y, Tsutsumi R, Fukata M, Keighren M, et al. Palmitoylation regulates epidermal homeostasis and hair follicle differentiation. PLoS Genet. 2009;5:e1000748.
Google Scholar
Huang J, Li J, Tang J, Wu Y, Dai F, Yi Z, et al. ZDHHC22-mediated mTOR palmitoylation restrains breast cancer growth and endocrine therapy resistance. Int J Biol Sci. 2022;18:2833–50.
Google Scholar
Fan X, Zhang S, Sun S, Bi W, Li S, Wang W, et al. GFAP palmitoylcation mediated by ZDHHC23 in spinal astrocytes contributes to the development of neuropathic pain. Reg Anesth Pain Med. 2024;49:821–30.
Dong G, Adak S, Spyropoulos G, Zhang Q, Feng C, Yin L, et al. Palmitoylation couples insulin hypersecretion with β cell failure in diabetes. Cell Metab. 2023;35:332–344.e337.
Google Scholar
Hellsten E, Vesa J, Olkkonen VM, Jalanko A, Peltonen L. Human palmitoyl protein thioesterase: evidence for lysosomal targeting of the enzyme and disturbed cellular routing in infantile neuronal ceroid lipofuscinosis. Embo J. 1996;15:5240–5.
Google Scholar
Cao M, Luo X, Wu K, He X. Targeting lysosomes in human disease: from basic research to clinical applications. Signal Transduct. Target Ther. 2021;6:379.
Google Scholar
Lin DT, Conibear E. ABHD17 proteins are novel protein depalmitoylases that regulate N-Ras palmitate turnover and subcellular localization. Elife. 2015;4:e11306.
Google Scholar
Tortosa E, Adolfs Y, Fukata M, Pasterkamp RJ, Kapitein LC, Hoogenraad CC. Dynamic palmitoylation targets MAP6 to the axon to promote microtubule stabilization during neuronal polarization. Neuron. 2017;94:809–825.e807.
Google Scholar
link